Literature DB >> 19291167

Abnormal platelet function in C3-deficient mice.

F C Gushiken1, H Han, J Li, R E Rumbaut, V Afshar-Kharghan.   

Abstract

UNLABELLED: SUMMARY
BACKGROUND AND OBJECTIVES: The complement system is a biochemical cascade composed of several plasma proteins that can interact with endothelial cells and blood cells, including platelets. In order to investigate the effect of the complement system on platelets, we studied platelet function in C3-deficient mice that lack complement activity. METHOD AND
RESULTS: Tail-cut bleeding time was prolonged and platelet aggregation in response to protease-activated receptor-4 (PAR4) peptide was decreased in C3-deficient mice as compared with wild-type littermates. Platelet aggregation in response to other agonists (ADP and collagen) was similar between C3-deficient mice and their normal littermates. Isolated platelets from wild-type mice aggregate less in C3-deficient plasma than in normal plasma, and, conversely, addition of plasma from wild-type mice or plasma-purified C3 improved aggregation of C3-deficient platelets. We also monitored the formation of murine arteriole or venule thrombi in an intravital microscopy thrombosis model. We found that C3-deficient mice had a significantly delayed thrombotic response in arterioles as compared with their wild-type littermates. Furthermore, thrombi in C3-deficient mice were less stable and embolized more frequently than those in wild-type mice.
CONCLUSIONS: Platelets of C3-deficient mice have subnormal function, resulting in a prolonged tail-cut bleeding time and delayed thrombosis after vessel wall injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19291167      PMCID: PMC2867673          DOI: 10.1111/j.1538-7836.2009.03334.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  21 in total

Review 1.  The response of human platelets to activated components of the complement system.

Authors:  P J Sims; T Wiedmer
Journal:  Immunol Today       Date:  1991-09

2.  Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity.

Authors:  P J Sims; E M Faioni; T Wiedmer; S J Shattil
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

3.  Platelet requirement in the interaction of the complement and clotting systems.

Authors:  R P Siraganian
Journal:  Nat New Biol       Date:  1972-10-18

4.  Endotoxin enhances microvascular thrombosis in mouse cremaster venules via a TLR4-dependent, neutrophil-independent mechanism.

Authors:  Rolando E Rumbaut; Ricardo V Bellera; Jaspreet K Randhawa; Corie N Shrimpton; Swapan K Dasgupta; Jing-Fei Dong; Alan R Burns
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-11-11       Impact factor: 4.733

5.  Immunological induction of increased vascular permeability. II. Two mechanisms of histamine release from rabbit platelets involving complement.

Authors:  P M Henson; C G Cochrane
Journal:  J Exp Med       Date:  1969-01-01       Impact factor: 14.307

6.  Activated platelets in paroxysmal nocturnal haemoglobinuria.

Authors:  H R Gralnick; M Vail; L P McKeown; P Merryman; O Wilson; I Chu; J Kimball
Journal:  Br J Haematol       Date:  1995-11       Impact factor: 6.998

7.  Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation.

Authors:  Anne-lie Ståhl; Fariba Vaziri-Sani; Stefan Heinen; Ann-Charlotte Kristoffersson; Karl-Henrik Gydell; Reem Raafat; Alberto Gutierrez; Ortraud Beringer; Peter F Zipfel; Diana Karpman
Journal:  Blood       Date:  2008-02-11       Impact factor: 22.113

8.  Blood coagulation initiation by a complement-mediated pathway.

Authors:  T S Zimmerman; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-12-01       Impact factor: 14.307

9.  The human complement system in thrombin-mediated platelet function.

Authors:  M J Polley; R Nachman
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

10.  Ultrastructural lesions on the surface of platelets associated with either blood coagulation or with antibody-mediated immune injury.

Authors:  M J Polley; R L Nachman
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

View more
  24 in total

1.  Contact activation of C3 enables tethering between activated platelets and polymorphonuclear leukocytes via CD11b/CD18.

Authors:  Osama A Hamad; Ioannis Mitroulis; Karin Fromell; Huda Kozarcanin; Triantafyllos Chavakis; Daniel Ricklin; John D Lambris; Kristina N Ekdahl; Bo Nilsson
Journal:  Thromb Haemost       Date:  2015-08-13       Impact factor: 5.249

Review 2.  Interactions between coagulation and complement--their role in inflammation.

Authors:  Katerina Oikonomopoulou; Daniel Ricklin; Peter A Ward; John D Lambris
Journal:  Semin Immunopathol       Date:  2011-08-03       Impact factor: 9.623

3.  Complement and clot.

Authors:  Vahid Afshar-Kharghan
Journal:  Blood       Date:  2017-04-20       Impact factor: 22.113

Review 4.  Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications.

Authors:  Shruti Chaturvedi; Evan M Braunstein; Robert A Brodsky
Journal:  J Thromb Haemost       Date:  2021-02-10       Impact factor: 5.824

Review 5.  Inducible innate resistance of lung epithelium to infection.

Authors:  Scott E Evans; Yi Xu; Michael J Tuvim; Burton F Dickey
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

6.  Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.

Authors:  Reinhard J Sauter; Manuela Sauter; Edimara S Reis; Frederic N Emschermann; Henry Nording; Sonja Ebenhöch; Peter Kraft; Patrick Münzer; Maximilian Mauler; Johannes Rheinlaender; Johannes Madlung; Frank Edlich; Tilman E Schäffer; Sven G Meuth; Daniel Duerschmied; Tobias Geisler; Oliver Borst; Meinrad Gawaz; Christoph Kleinschnitz; John D Lambris; Harald F Langer
Journal:  Circulation       Date:  2018-10-16       Impact factor: 29.690

7.  Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development.

Authors:  Saravanan Subramaniam; Kerstin Jurk; Lukas Hobohm; Sven Jäckel; Mona Saffarzadeh; Kathrin Schwierczek; Philip Wenzel; Florian Langer; Christoph Reinhardt; Wolfram Ruf
Journal:  Blood       Date:  2017-02-21       Impact factor: 22.113

8.  Standardizing a simpler, more sensitive and accurate tail bleeding assay in mice.

Authors:  Yang Liu; Nicole L Jennings; Anthony M Dart; Xiao-Jun Du
Journal:  World J Exp Med       Date:  2012-04-20

Review 9.  STEC-HUS, atypical HUS and TTP are all diseases of complement activation.

Authors:  Marina Noris; Federica Mescia; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2012-09-18       Impact factor: 28.314

Review 10.  Interplay between inflammation and thrombosis in cardiovascular pathology.

Authors:  Konstantin Stark; Steffen Massberg
Journal:  Nat Rev Cardiol       Date:  2021-05-06       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.